The following is a guest post by Jim Connolly, president and CEO of Aeras, a nonprofit product development partnership dedicated to the development of tuberculosis vaccines. Aeras is located in Rockville, MD and operates an office in Cape Town, South Africa. By Jim Connolly Recently I had the privilege of visiting our colleagues and partners […]
The potential for antiretroviral medicine to reduce transmission of HIV and tuberculosis has been demonstrated, but the challenges of using treatment to prevent infection will need to be tackled country by country, and with focus on people for whom it will have the biggest impact, the latest bulletin on HIV treatment from the World Health […]
The 2013 health funding bill passed by the Senate Appropriations Committee brings good news for tuberculosis research advocates, keeping funding for the Centers for Disease Control and Prevention’s Division of TB Elimination at its current $140.298 million. The Obama administration had recommended a $4.6 million cut. While about 80 percent of the CDC’s TB division […]
The Kaiser Family Foundation’s panel talk on changes at The Global Fund to Fight AIDS, Tuberculosis and Malaria, focused on the impact of reorganization at the charity at a time when scientific progress offers unprecedented chances for inroads against the diseases. Panelists Joanne Carter, executive director of RESULTS/RESULTS EDUCATION FUND, J. Stephen Morrison, senior vice […]
On June 12, a Senate funding subcommittee voted on funding allocations for programs in health, human services, labor and education for the federal fiscal year beginning October 1, 2012. Many details have not been released and more information will become available when the full Senate appropriations committee votes on the bill on Thursday, June 14. […]
Facing uncertain future funding, countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis, and Malaria have used what they know about their own epidemics to redirect money to programs where it will have its greatest impact, the latest edition of Aidspan’s Global Fund Observer reports. The Fund has encouraged the effort during renewal […]
Researchers who tested the safety and effectiveness of a new approach to tuberculosis treatment in recent global clinical trials are saying the results offer hope that a drug that could shorten the period during which patients can spread the disease to others, while addressing multi-drug-resistant infections. Researchers are calling the development of a new drug […]
HIV
Steeped in inequities that include formidable barriers to basic health services for multitudes of its most vulnerable, marginalized and neglected people, the country leading global HIV […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
With 2018 data showing highest incidence acute flaccid myelitis since monitoring began, officials say awareness, recognition of rare life threatening condition will be crucial to early […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]